Irinotecan Liposome II in Combination With 5-FU/LV and Oxaliplatin in Perioperative Treatment of Borderline Resectable Pancreatic Cancer
Conditions: Borderline Resectable Pancreatic Cancer Interventions: Drug: irinotecan liposome II combined with 5-FU/LV and oxaliplatin Sponsors: Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2024 Category: Research Source Type: clinical trials
Pharmacokinetics, Biodistribution, Radiation Dose and Safety Study of 68Ga-NYM032 in Patients
Conditions: Prostate Cancer Interventions: Drug: 68Ga-NYM032 injection Sponsors: Norroy Bioscience Co., LTD Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2024 Category: Research Source Type: clinical trials
Neoadjuvant Lu-PSMA Radioligand Therapy and Ipilimumab in Men With Very High-risk Prostate Cancer
Conditions: Very High Risk Prostate Carcinoma Interventions: Radiation: [177Lu]Lu-PSMA-617; Drug: Ipilimumab Sponsors: University Hospital, Essen; Advanced Accelerator Applications; Bristol-Myers Squibb Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2024 Category: Research Source Type: clinical trials
Co-Design and Pilot Testing of Peer-led Community Outreach to Improve Equity, Veteran-Centeredness and Uptake of Lung Cancer Screening
Conditions: Lung Cancer Interventions: Other: Veterans peer connect Program Sponsors: VA Boston Healthcare System Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2024 Category: Research Source Type: clinical trials
Tailoring Therapy in Post-surgical Patients With Low-risk Endometrial Cancer
Conditions: Stage I Uterine Corpus Endometrial Stromal Sarcoma AJCC V8; Stage II Uterine Corpus Endometrial Stromal Sarcoma AJCC V8; Stage III Uterine Corpus Endometrial Stromal Sarcoma AJCC V8 Interventions: Other: Clinical Observation; Radiation: External Beam Radiation Therapy; Procedure: High-Dose-Rate Vaginal Brachytherapy; Procedure: Computed Tomography; Procedure: Positron Emission Tomography; Procedure: X-Ray Imaging; Procedure: Magnetic Resonance Imaging; Other: Questionnaire Administration Sponsors: NRG Oncology; National Cancer Institute (NCI); Canadian Cancer Trials Group Suspended (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2024 Category: Research Source Type: clinical trials
Namodenoson Treatment of Advanced Pancreatic Cancer
Conditions: Pancreatic Adenocarcinoma; Pancreatic Cancer Interventions: Drug: Namodenoson 25mg Sponsors: Can-Fite BioPharma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2024 Category: Research Source Type: clinical trials
Whole-slide Image and CT Radiomics Based Deep Learning System for Prognostication Prediction in Bladder Cancer
Conditions: Bladder Cancer Interventions: Other: Deep learning system for prognostication prediction in bladder cancer Sponsors: Mingzhao Xiao Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2024 Category: Research Source Type: clinical trials
To Evaluate the Efficacy and Safety of Disitamab Vedotin Combined With Toripalimab Sequential Chemotherapy as Neoadjuvant Treatment in Patients With HR-positive, HER2-low Breast Cancer
Conditions: HR-positive, HER2-low Breast Cancer Interventions: Drug: Disitamab Vedotin for Injection; Drug: Toripalimab; Drug: Epirubicin; Drug: Cyclophosphamide Sponsors: RemeGen Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2024 Category: Research Source Type: clinical trials
LM-108 in Combination With PD-1 Based Treatment for Patients With Recurrent or Metastatic Triple - Negative Breast Cancer
Conditions: TNBC - Triple-Negative Breast Cancer Interventions: Drug: LM-108; Drug: Toripalimab; Drug: Eribulin; Drug: Nab paclitaxel Sponsors: Fudan University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2024 Category: Research Source Type: clinical trials
Long-term Observational Study to Evaluate the DFS and OS of Adjuvant FOLFIRINOX Regimen in Pancreatic Cancer Patients
Conditions: Adjuvant Chemotherapy Sponsors: HK inno.N Corporation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2024 Category: Research Source Type: clinical trials
HAIC+Adebrelimab+Lenvatinib for Conversion Treatment of Potentially Resectable, Locally Advanced Biliary Tract Cancer
Conditions: Biliary Tract Cancer Interventions: Drug: Adebrelimab; Drug: Lenvatinib; Procedure: Hepatic Arterial Infusion Chemotherapy Sponsors: Harbin Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2024 Category: Research Source Type: clinical trials
Clinical Study of Huaier Granule in the Treatment of Unresectable Pancreatic Cancer
Conditions: Pancreatic Cancer Non-resectable Interventions: Drug: Huaier Granule; Drug: Capecitabine Sponsors: Health Science Center of Xi ' an Jiaotong University; LinkDoc Technology (Beijing) Co. Ltd.; Huazhong University of Science and Technology Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2024 Category: Research Source Type: clinical trials
Study on the Quality of Life and Functional/Oncological Outcome of Testicular Cancer Patients
Conditions: Testicular Cancer Interventions: Other: Observation of testicular cancer patients Sponsors: IRCCS San Raffaele Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2024 Category: Research Source Type: clinical trials
SPECT Imaging for Pharmacokinetics and dosimEtry Towards TREATment Optimization
Conditions: Prostate Cancer; Advanced Cancer Interventions: Radiation: Radium-223; Radiation: 177Lu-DOTATATE; Radiation: 177Lu-PSMA-617 Sponsors: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2024 Category: Research Source Type: clinical trials
RC48 Combined With Adebrelimab and Apatinib and S-1 of the Neoadjuvant Therapy of Locally Advanced Gastric Cancer
Conditions: Gastric Cancer/Gastroesophageal Junction Adenocarcinoma Interventions: Drug: RC48; Drug: Adebrelimab; Drug: Apatinib; Drug: S-1 Sponsors: The First Affiliated Hospital with Nanjing Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2024 Category: Research Source Type: clinical trials
